Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l

Details Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l

1991-09-09

1993-11-30

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514492, 514866, 514188, 546 5, A61K 31555, C07D21389

Patent

active

052665607

ABSTRACT:
A composition of matter having GTF-like activity, its preparation and its use in treating chromium deficiency and insulin resistance diseases such as diabetes are set forth. The composition comprises: ##STR1## m=1, 2 or 3; n=0, 1 or 2; p=0, 1, 2, 3, 4 or 5; q=0, 1, 2, 3, 4 or 5; r=0, 1, 2 or 3;

REFERENCES:
patent: 4343905 (1982-08-01), Szalay
patent: 4921877 (1990-05-01), Cashmere et al.
patent: 4923855 (1990-05-01), Jensen
patent: 4954492 (1990-09-01), Jensen
patent: 4985439 (1991-01-01), Hwang et al.

Affiliated with

Also associated with

Rating

Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical insulin-potentiating CR(III) complexes with GTF-l will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2096321